Myrica ER Tablet 82.5 mg contains Pregabalin, a central nervous system-acting anticonvulsant and neuropathic pain modulator formulated in an extended-release (ER) form. Pregabalin works by binding to the α2-δ subunit of voltage-gated calcium channels in nerve cells, reducing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. This action dampens abnormal nerve activity, providing relief from neuropathic pain, seizures, and symptoms of generalized anxiety disorder.

The extended-release formulation of Myrica ER 82.5 mg allows once-daily dosing, maintaining stable plasma concentrations throughout the day. This improves patient adherence, reduces fluctuations in drug levels, and enhances long-term symptom control. It is particularly suitable for patients requiring convenient, consistent management of chronic neuropathic pain or epilepsy

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
.

Indications

Myrica ER Tablet 82.5 mg is indicated for:

• Neuropathic pain, including:

  • Diabetic peripheral neuropathy

  • Postherpetic neuralgia

  • Pain following spinal cord injury or nerve compression

• Adjunctive therapy for partial-onset seizures in adults

• Generalized anxiety disorder (GAD) in adults where first-line therapies are inadequate

• Chronic fibromyalgia or musculoskeletal pain as part of multimodal therapy

The ER formulation is especially helpful in patients who require continuous symptom control without multiple daily doses, improving comfort, sleep, and daily functioning.

Dosage and Administration

Recommended dosage:

• Adults: Typically 82.5 mg once daily, preferably at the same time each day

• Dose may be titrated upward gradually based on clinical response and tolerability

• Dose adjustments are necessary for elderly patients or those with renal impairment

• Maximum daily dose is determined by the physician depending on severity and type of condition

Administration guidelines:

• Take the tablet whole with a full glass of water

• Can be taken with or without food

• Do not crush, chew, or break the tablet, as this will destroy the extended-release mechanism

• Maintain consistent daily timing to achieve optimal therapeutic effect

• Avoid abrupt discontinuation to prevent withdrawal symptoms such as insomnia, anxiety, or nausea

Precautions and Warnings

• Allergy warning: Avoid in patients with hypersensitivity to Pregabalin or any excipient

• Renal impairment: Dose adjustment is required for patients with kidney dysfunction

• Pregnancy and breastfeeding: Use only if clearly indicated and under medical supervision

• Caution: May cause dizziness, drowsiness, or blurred vision; patients should avoid driving or operating machinery if affected

• Drug interactions: Caution with CNS depressants, alcohol, or opioids, which may enhance sedative effects

• Dependence and withdrawal: Gradual tapering is recommended to minimize withdrawal symptoms

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Myrica ER Tablet 82.5 mg is generally well tolerated. Common side effects include:

• Dizziness or lightheadedness

• Drowsiness or mild fatigue

• Peripheral edema or weight gain

• Dry mouth or mild gastrointestinal upset

• Rare: blurred vision, allergic reactions, or muscle cramps

Most side effects are dose-dependent and transient. Severe adverse reactions require immediate medical attention.

Storage

Store in a cool, dry place below 25°C, protected from light and moisture. Keep tablets in their original packaging and out of reach of children.

Myrica ER Tablet 82.5 mg (Pregabalin) provides effective, long-acting relief for neuropathic pain, seizures, and anxiety disorders, offering convenient once-daily dosing, stable symptom control, and improved patient adherence in chronic therapy.